Back
Moleculin Biotech Vs. Cara Therapeutics Industry Stock Comparison
Sell
15
MBRX
Moleculin Biotech
Last Price:
2.41
Seasonality Move:
-17.51%
Sell
11
CARA
Cara Therapeutics
Last Price:
0.30
Seasonality Move:
-11.19%
Sell
15
Moleculin Biotech (MBRX)
is a Sell
Is Moleculin Biotech a Buy, Sell or Hold?
- The current Moleculin Biotech [MBRX] share price is $2.31. The Score for MBRX is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
- MBRX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
11
Cara Therapeutics (CARA)
is a Sell
Is Cara Therapeutics a Buy, Sell or Hold?
- The current Cara Therapeutics [CARA] share price is $0.29. The Score for CARA is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
- CARA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
MBRX Stock Price Chart
What is Moleculin Biotech's stock price today?
-
The Moleculin Biotech share price today is $2.31
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MBRX is experiencing selling pressure, which indicates risk of future bearish movement.
CARA Stock Price Chart
What is Cara Therapeutics's stock price today?
-
The Cara Therapeutics share price today is $0.29
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CARA is experiencing selling pressure, which indicates risk of future bearish movement.
MBRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.09 | Sell |
| Relative Strength Index (14 RSI): | 40.34 | Sell |
| Chaikin Money Flow: | -11199 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.37 - 2.51) | Sell |
| Bollinger Bands (100): | (2.56 - 4.6) | Sell |
CARA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 43.76 | Sell |
| Chaikin Money Flow: | -366348 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.29 - 0.35) | Sell |
| Bollinger Bands (100): | (0.26 - 0.64) | Sell |
MBRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.39 | Sell |
| 20-day SMA: | 2.43 | Sell |
| 50-day SMA: | 2.81 | Sell |
| 200-day SMA: | 5.74 | Sell |
| 8-day EMA: | 2.38 | Sell |
| 20-day EMA: | 2.44 | Sell |
| 50-day EMA: | 2.81 | Sell |
| 200-day EMA: | 5.24 | Sell |
CARA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.28 | Buy |
| 20-day SMA: | 0.31 | Sell |
| 50-day SMA: | 0.33 | Sell |
| 200-day SMA: | 0.61 | Sell |
| 8-day EMA: | 0.29 | Buy |
| 20-day EMA: | 0.31 | Sell |
| 50-day EMA: | 0.35 | Sell |
| 200-day EMA: | 0.92 | Sell |
Moleculin Biotech Earnings Growth & MBRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.79 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.06 per share, and an increase next year of $8.81 per share.
Cara Therapeutics Earnings Growth & CARA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and an increase next year of $0.52 per share.
Moleculin Biotech Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cara Therapeutics Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||